Shukra Pharmaceuticals Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Excellent return on equity (ROE 28.9%)
- Efficient capital deployment (ROCE 37%)
Concerns
- Premium to sector peers (P/E 84x vs industry 50.2x)
- Trading near 52-week high (₹77)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SHUKRAPHAR · as of Sep 2026
| Category | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Promoters | 50.95% | 50.95% | 50.95% | 50.95% | 50.95% | 50.95% |
| DII | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Public | 48.93% | 48.93% | 48.93% | 48.93% | 48.93% | 48.93% |
Latest News
All newsShukra Pharma sets dividend record date for Sept 2026
*Shukra Pharma sets dividend record date for Sept 2026.* The company has announced **21-Sep-2026** as the record date for dividend distribution. This is a routine corporate action with no immediate cash flow impact. Shareholders registered by the date will be eligible for the declared dividend. 📊 *STOCKS:* $SHUKRAPHARM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend
Shukra Pharmaceuticals issues general corporate updates
*Shukra Pharmaceuticals issues general corporate updates.* The company filed routine updates with the NSE, without disclosing specific financial or operational details. Such filings typically include administrative or procedural information. No immediate market-moving developments were indicated. 📊 *STOCKS:* SHUKRAPHARM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporate